Table 2.
Group | Dose (mg/L) | APTT (s) | PT (s) | TT(s) |
---|---|---|---|---|
Control | 25.67 ± 2.75 | 14.60 ± 1.05 | 19.4 ± 0.95 | |
LSP | 50 | 32.57 ± 2.93a | 17.37 ± 0.85 | 26.7 ± 1.25b |
100 | 54.93 ± 1.88b | 23.27 ± 1.60b | 30.43 ± 1.86b | |
150 | 67.57 ± 3.89b | 27.50 ± 2.10b | 37.07 ± 1.90b | |
200 | 87.03 ± 2.53b | 32.17 ± 2.48b | 58.83 ± 2.25b | |
Asp | 50 | 119.23 ± 3.55b | 39.73 ± 2.60b | 85.20 ± 2.72b |
p < 0.05,
p < 0.01, compared with the control group.